Corvus Pharmaceuticals, Inc.
CRVS
$14.08
-$1.37-8.87%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
2/2/2026
-
MarketBeat
3/19/2026
-
Tickeron - Technical Analysis
3/19/2026
-
Tickeron - Technical Analysis
3/18/2026
-
Simply Wall St
3/16/2026
-
MarketBeat
3/15/2026
-
Simply Wall St
3/14/2026
-
MarketBeat
3/14/2026
-
TipRanks Financial Blog
3/13/2026
-
MarketBeat
3/13/2026
-
MarketBeat
3/13/2026
-
Ticker Report
3/13/2026
-
TipRanks Financial Blog
3/13/2026
-
Simply Wall St
3/13/2026
-
SeekingAlpha
3/13/2026
-
Seeking Alpha: Transcripts
3/12/2026
-
MarketBeat
3/12/2026
-
MarketBeat
3/12/2026
-
TipRanks Financial Blog
3/12/2026
-
Globe Newswire
3/12/2026
-
TipRanks Financial Blog
3/12/2026
-
The Fly
3/12/2026
-
TipRanks Financial Blog
3/12/2026
-
MarketBeat
3/9/2026
-
Simply Wall St
3/7/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 12, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 900 4520
Address
901 Gateway Boulevard
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell...
more